Genetic susceptibility to rheumatoid arthritis and its implications for novel drug discovery
- 7 June 2016
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Discovery
- Vol. 11 (8) , 805-813
Abstract
Introduction: Over 100 susceptibility loci have now been identified for rheumatoid arthritis (RA), several of which are already the targets of approved RA therapies providing proof of concept for the use of genetics in novel drug development for RA. Determining how these loci contribute to disease will be key to elucidating the mechanisms driving disease development, which has the potential for major impact on therapeutic development. Areas covered: Here the authors review the use of genetics in drug discovery, including the use of ‘omics’ data to prioritise potential drug targets at susceptibility loci using RA as an exemplar. They discuss the current state of RA genetics its impact on stratified medicine, and how the findings from RA genetics studies can be used to inform drug discovery. Expert opinion: It is anticipated that functional characterisation of disease variants will provide biological validation of a gene as a drug target, providing safer targets, with an increased likelihood of efficacy. In the future, techniques such as genome editing may represent a plausible option for RA therapy. Technologies such as genome-wide chromatin conformation capture Hi-C and CRISPR will be crucial to inform our understanding of how diseases develop and in developing new treatments.Keywords
Funding Information
- Arthritis Research UK (20385)
- BTCURE (115142-2)
This publication has 52 references indexed in Scilit:
- High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritisNature Genetics, 2012
- Genetics of gene expression in primary immune cells identifies cell type–specific master regulators and roles of HLA allelesNature Genetics, 2012
- Long-range DNA looping and gene expression analyses identify DEXI as an autoimmune disease candidate geneHuman Molecular Genetics, 2011
- Reduction of long‐term disability in inflammatory polyarthritis by early and persistent suppression of joint inflammation: Results from the Norfolk Arthritis RegisterArthritis Care & Research, 2011
- Hundreds of variants clustered in genomic loci and biological pathways affect human heightNature, 2010
- From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locusNature, 2010
- High-Resolution Profiling of Histone Methylations in the Human GenomeCell, 2007
- Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart DiseaseNew England Journal of Medicine, 2006
- Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotypeProceedings of the National Academy of Sciences, 2004
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003